{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:05:12Z","timestamp":1791515112291,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018552","name":"Science and Technology Plan Project of Taizhou","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017577","name":"Zhejiang Province Basic Public Welfare Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017577","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.mce.2024.112382","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T18:50:35Z","timestamp":1727549435000},"page":"112382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["NLRP3 blockade by MCC950 suppressed osteoclastogenesis via NF-\u03baB\/c-Fos\/NFATc1 signal pathway and alleviated bone loss in diabetes mellitus"],"prefix":"10.1016","volume":"594","author":[{"given":"Guoping","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoyuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengteng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhuan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0515-9841","authenticated-orcid":false,"given":"Liwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2024.112382_bib1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1074-7613(04)00046-9","article-title":"NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder","volume":"20","author":"Agostini","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.mce.2024.112382_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.981487","article-title":"The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: the mechanisms and roles of increased bone marrow adiposity","volume":"13","author":"Ali","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mce.2024.112382_bib3","doi-asserted-by":"crossref","first-page":"6630","DOI":"10.1038\/s41598-017-07014-0","article-title":"Bone matrix components activate the NLRP3 inflammasome and promote osteoclast differentiation","volume":"7","author":"Alippe","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mce.2024.112382_bib4","doi-asserted-by":"crossref","first-page":"12515","DOI":"10.1096\/fj.201802805RR","article-title":"Activation of ROS\/MAPKs\/NF-\u03baB\/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis","volume":"33","author":"An","year":"2019","journal-title":"Faseb. J. : official publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.mce.2024.112382_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ecl.2012.04.006","article-title":"Pathophysiology of osteoporosis: new mechanistic insights","volume":"41","author":"Armas","year":"2012","journal-title":"Endocrinol Metab. Clin. N. Am."},{"key":"10.1016\/j.mce.2024.112382_bib6","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1210\/js.2019-00160","article-title":"Advanced glycation end products (AGEs), receptor for AGEs, diabetes, and bone: review of the literature","volume":"3","author":"Asadipooya","year":"2019","journal-title":"Journal of the Endocrine Society"},{"key":"10.1016\/j.mce.2024.112382_bib7","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1089\/scd.2014.0484","article-title":"The role of reactive oxygen species in mesenchymal stem cell adipogenic and osteogenic differentiation: a review","volume":"24","author":"Atashi","year":"2015","journal-title":"Stem Cell. Dev."},{"key":"10.1016\/j.mce.2024.112382_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108595","article-title":"MCC950 in the treatment of NLRP3-mediated inflammatory diseases: latest evidence and therapeutic outcomes","volume":"106","author":"Bakhshi","year":"2022","journal-title":"Int. Immunopharm."},{"issue":"183","key":"10.1016\/j.mce.2024.112382_bib9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","author":"Bauernfeind","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.mce.2024.112382_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/oby.2010.106","article-title":"Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women. Obesity","volume":"19","author":"Bredella","year":"2011","journal-title":"Silver Spring, Md.)"},{"key":"10.1016\/j.mce.2024.112382_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122185","article-title":"NLRP3-inflammasome inhibition by MCC950 attenuates cardiac and pulmonary artery remodelling in heart failure with preserved ejection fraction","volume":"333","author":"Cheng","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.mce.2024.112382_bib12","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","article-title":"TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling","volume":"78","author":"Ciesielska","year":"2021","journal-title":"Cell. Mol. Life Sci. : CMLS"},{"key":"10.1016\/j.mce.2024.112382_bib13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.mce.2024.112382_bib14","first-page":"372","article-title":"Obesity, osteoporosis and bone metabolism","volume":"20","author":"Gkastaris","year":"2020","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.mce.2024.112382_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1071465","article-title":"Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: evidence from NHANES 2011-2018","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mce.2024.112382_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S2213-8587(21)00347-8","article-title":"Bone fragility in diabetes: novel concepts and clinical implications","volume":"10","author":"Hofbauer","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.mce.2024.112382_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.752546","article-title":"NLRP3 inflammasome: a new target for prevention and control of osteoporosis?","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mce.2024.112382_bib18","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ecl.2005.07.009","article-title":"Pathophysiology of age-related bone loss and osteoporosis","volume":"34","author":"Khosla","year":"2005","journal-title":"Endocrinol Metab. Clin. N. Am."},{"key":"10.1016\/j.mce.2024.112382_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12964-023-01226-w","article-title":"Concomitant induction of SLIT3 and microRNA-218-2 in macrophages by toll-like receptor 4 activation limits osteoclast commitment","volume":"21","author":"Kim","year":"2023","journal-title":"Cell Commun. Signal. : CCS"},{"key":"10.1016\/j.mce.2024.112382_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00198-017-4223-9","article-title":"Effects of obesity and diabetes on rate of bone density loss","volume":"29","author":"Leslie","year":"2018","journal-title":"Osteoporos. Int. : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"10.1016\/j.mce.2024.112382_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/GME.0000000000000732","article-title":"To assess differential features of marrow adiposity between postmenopausal women with osteoarthritis and osteoporosis using water\/fat MRI","volume":"24","author":"Li","year":"2017","journal-title":"Menopause"},{"key":"10.1016\/j.mce.2024.112382_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175091","article-title":"Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome","volume":"928","author":"Li","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.mce.2024.112382_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.clim.2012.12.006","article-title":"Specific inflammasomes in complex diseases","volume":"147","author":"Masters","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.mce.2024.112382_bib24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mce.2024.112382_bib25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2016.153","article-title":"Mechanisms of diabetes mellitus-induced bone fragility","volume":"13","author":"Napoli","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.mce.2024.112382_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph13111067","article-title":"Diabetes and obesity as independent risk factors for osteoporosis: updated results from the ROIS\/EMEROS registry in a population of five thousand post-menopausal women living in a region characterized by heavy environmental pressure","volume":"13","author":"Neglia","year":"2016","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.mce.2024.112382_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.mce.2024.112382_bib28","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1007\/s00198-006-0155-5","article-title":"Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN\/Kob rats","volume":"17","author":"Saito","year":"2006","journal-title":"Osteoporos. Int. : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"10.1016\/j.mce.2024.112382_bib29","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.mce.2024.112382_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.tem.2022.02.006","article-title":"Assessment and treatment of osteoporosis and fractures in type 2 diabetes","volume":"33","author":"Sheu","year":"2022","journal-title":"Trends Endocrinol. Metabol.: TEM"},{"key":"10.1016\/j.mce.2024.112382_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.mce.2024.112382_bib32","article-title":"Pyroptosis in osteoblasts: a novel hypothesis underlying the pathogenesis of osteoporosis","volume":"11","author":"Tao","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mce.2024.112382_bib33","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/jbmr.3408","article-title":"High-fat diet-induced obesity promotes expansion of bone marrow adipose tissue and impairs skeletal stem cell functions in mice","volume":"33","author":"Tencerova","year":"2018","journal-title":"J. Bone Miner. Res. : the official journal of the American Society for Bone and Mineral Research"},{"key":"10.1016\/j.mce.2024.112382_bib34","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.celrep.2019.04.066","article-title":"Obesity-associated hypermetabolism and accelerated senescence of bone marrow stromal stem cells suggest a potential mechanism for bone fragility","volume":"27","author":"Tencerova","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.mce.2024.112382_bib35","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s00223-016-0229-0","article-title":"Obesity, type 2 diabetes and bone in adults","volume":"100","author":"Walsh","year":"2017","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.mce.2024.112382_bib36","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.bbrc.2017.02.007","article-title":"NLRP3 inflammasome activation in mesenchymal stem cells inhibits osteogenic differentiation and enhances adipogenic differentiation","volume":"484","author":"Wang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2024.112382_bib37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.phrs.2019.01.035","article-title":"NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia","volume":"142","author":"Ward","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.mce.2024.112382_bib38","article-title":"Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome in systemic lupus erythematosus","volume":"172","author":"Wu","year":"2024","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.mce.2024.112382_bib39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cmet.2013.09.010","article-title":"Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging","volume":"18","author":"Youm","year":"2013","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mce.2024.112382_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98437-3","article-title":"The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages","volume":"11","author":"Zeng","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mce.2024.112382_bib41","article-title":"MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis","volume":"143","author":"Zhang","year":"2021","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.mce.2024.112382_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174176","article-title":"Inhibition of osteoclastogenesis by histone deacetylase inhibitor Quisinostat protects mice against titanium particle-induced bone loss","volume":"904","author":"Zhang","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.mce.2024.112382_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.714943","article-title":"Janus kinase inhibition ameliorates ischemic stroke injury and neuroinflammation through reducing NLRP3 inflammasome activation via JAK2\/STAT3 pathway inhibition","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Immunol."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720724002387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720724002387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T23:46:37Z","timestamp":1730418397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720724002387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":43,"alternative-id":["S0303720724002387"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2024.112382","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NLRP3 blockade by MCC950 suppressed osteoclastogenesis via NF-\u03baB\/c-Fos\/NFATc1 signal pathway and alleviated bone loss in diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2024.112382","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112382"}}